Global Biotech Breakthroughs

Madrigal Pharmaceuticals

Market Cap: US$11.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Travere Therapeutics

Market Cap: US$2.9b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Ascelia Pharma

Market Cap: SEK 366.7m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥25.8b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$113.1b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

CARsgen Therapeutics Holdings

Market Cap: HK$9.9b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Syndax Pharmaceuticals

Market Cap: US$2.2b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Precigen

Market Cap: US$1.5b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Elicera Therapeutics

Market Cap: SEK 267.9m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Insmed

Market Cap: US$34.6b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

HansBiomed

Market Cap: ₩425.7b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

Marker Therapeutics

Market Cap: US$24.3m

A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Rhythm Pharmaceuticals

Market Cap: US$5.8b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.

Akeso

Market Cap: HK$124.8b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Cogent Biosciences

Market Cap: US$6.0b

A clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases.

3billion

Market Cap: ₩355.7b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

Guard Therapeutics International

Market Cap: SEK 24.2m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Mesoblast

Market Cap: AU$2.6b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Pelthos Therapeutics

Market Cap: US$76.8m

A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

DBV Technologies

Market Cap: €996.1m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Capricor Therapeutics

Market Cap: US$1.8b

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Tenaya Therapeutics

Market Cap: US$157.4m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Aldeyra Therapeutics

Market Cap: US$94.5m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.

Lineage Cell Therapeutics

Market Cap: US$376.1m

A clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.

RenovoRx

Market Cap: US$44.1m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

ARS Pharmaceuticals

Market Cap: US$813.2m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.

CG Oncology

Market Cap: US$5.8b

A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.

Oxford Biomedica

Market Cap: UK£683.1m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Lipigon Pharmaceuticals

Market Cap: SEK 3.5m

A clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden.

AC Immune

Market Cap: US$318.4m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Arcutis Biotherapeutics

Market Cap: US$3.1b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Humacyte

Market Cap: US$144.6m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

CollPlant Biotechnologies

Market Cap: US$5.5m

A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.

Viridian Therapeutics

Market Cap: US$1.5b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Devyser Diagnostics

Market Cap: SEK 1.3b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.